Time for some fireworks and BBQ

July 4th is once again rolling around and FierceBiotech will be taking a brief retreat from deadlines to enjoy some fireworks and BBQ. But we'll be back bright and early on Thursday to resume our regular stream of R&D reports from the biopharma front. For our U.S. audience, we hope you have a safe and fun holiday. For the rest of the world, pardon the hiatus. Holidays happen. -- John Carroll, Editor-in-Chief. Follow me on Twitter and LinkedIn.

Suggested Articles

Antivirals from Roche, Bristol Myers Squibb, Viiv and Gilead, or modified versions of them, could prove effective against COVID-19, researchers said.

After posting positive data that showed it could help slow down the degenerative ALS disease, Amylyx has been given a $30 million boost.

Sumitomo is looking to the merged pipeline to help offset the anticipated impact of the arrival of generic competitors to bipolar drug Latuda.